A Novel Oral Natural Extract for the Treatment of Senile Purpura

A Randomized, Double-Blind, Placebo-Controlled Study To Assess the Safety and Efficacy of a Novel Oral Natural Extract for the Treatment of Senile Purpura

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01183910

Enrollment

Registered

2010-08-18

Start date

2008-11-30

Completion date

2011-08-31

Last updated

2011-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PURPURA

Keywords

PURPURA, SENILE PURPURA, BATEMAN'S PURPURA

Brief summary

A randomized, double-blind, placebo controlled study to assess the safety and effectiveness of a novel oral natural extract to improve the appearance of the skin of patients with senile purpura.

Interventions

DIETARY_SUPPLEMENTCitrus Bioflavanoid Blend

Pill Taken Twice a Day

DIETARY_SUPPLEMENTCalcium Carbonate

Oral Tablet Taken Twice a Day

Study design

Allocation

RANDOMIZED

Intervention model

SINGLE_GROUP

Masking

DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender

ALL

Age

40 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Patients with evidence of purpura on physical exam

Exclusion criteria

* Preexisting condition that would not allow the patients to take oral calcium supplement

Design outcomes

Primary

Measure	Time frame
IMPROVEMENT IN PATIENT'S SKIN APPEARANCE WITH SENILE PURPURA	6 WEEKS

Secondary

Measure	Time frame
ADVERSE EFFECTS IN PATIENTS WITH SENILE PURPURA TAKING THIS MEDICATION	6 WEEKS

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026